IL6 and Sepsis: These results demonstrate (2S)-OMPT has therapeutic implications for sepsis-related tissue damage and thrombosis through inhibition of IL-6 and IL-8 induced NETs formation, possibly contributing to the future clinical treatment of sepsis.